Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) -- IREN (Iris Energy Limited) (NASDAQ: IREN ) (together with its subsidiaries, "IREN" or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today provided a business update. ...

Stellantis to Announce First Half 2024 Results on July 25 AMSTERDAM, July 1, 2024 - Stellantis N.V. announced today that its First Half 2024 Results will be released on Thursday, July 25, 2024. A live webcast and conference call of the First Half 2024 Results will begin at 2:00 ...

First non-Bentley family member to lead company, Cumins unveils vision for infrastructure resilience powered by AI, focus on operations phase of lifecycle Following the CEO transition plan previously announced by Bentley Systems, Incorporated (Nasdaq: BSY), Nicholas Cumins today takes c...

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...

MEDIA ALERT: Equinix Sets Conference Call for Second-Quarter PR Newswire REDWOOD CITY, Calif. , July 1, 2024 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company ® , today announced that it will hold its quarterly ...

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer PR Newswire As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman Robert A. Michael Joins AbbVie Board of Directors NORTH CHICAGO, Ill....

Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...

NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug PR Newswire Disease progression was slowed by 36% (p=...

CAMPBELL, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that it has joined the broad-market Russell 2000® Index. “We are excited to be included in the Russel...

SIGMA LITHIUM SELLS 22,000t OF QUINTUPLE ZERO LITHIUM AT PREMIUM PRICE OF 8.75% LME HYDROXIDE Canada NewsWire HIGHLIGHTS Sigma Lithium completed the sale of its 10 th shipment of 22,000t of Quintuple Zero Green Lithium at a premium floating price of 8.75% of LME ...